rs1272886269
Variant summary
Our verdict is Pathogenic. Variant got 18 ACMG points: 18P and 0B. PVS1PM2PP5_Very_Strong
The NM_001127222.2(CACNA1A):c.1082+1G>A variant causes a splice donor, intron change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.00000069 in 1,449,032 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. 3/3 splice prediction tools predicting alterations to normal splicing. Variant has been reported in ClinVar as Pathogenic (★★).
Frequency
Consequence
NM_001127222.2 splice_donor, intron
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 18 ACMG points.
Transcripts
RefSeq
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
CACNA1A | ENST00000360228.11 | c.1082+1G>A | splice_donor_variant, intron_variant | Intron 7 of 46 | 1 | NM_001127222.2 | ENSP00000353362.5 | |||
CACNA1A | ENST00000638029.1 | c.1082+1G>A | splice_donor_variant, intron_variant | Intron 7 of 47 | 5 | ENSP00000489829.1 | ||||
CACNA1A | ENST00000573710.7 | c.1082+1G>A | splice_donor_variant, intron_variant | Intron 7 of 46 | 5 | ENSP00000460092.3 | ||||
CACNA1A | ENST00000635727.1 | c.1082+1G>A | splice_donor_variant, intron_variant | Intron 7 of 46 | 5 | ENSP00000490001.1 | ||||
CACNA1A | ENST00000637769.1 | c.1082+1G>A | splice_donor_variant, intron_variant | Intron 7 of 46 | 1 | ENSP00000489778.1 | ||||
CACNA1A | ENST00000636012.1 | c.1082+1G>A | splice_donor_variant, intron_variant | Intron 7 of 45 | 5 | ENSP00000490223.1 | ||||
CACNA1A | ENST00000637736.1 | c.941+1G>A | splice_donor_variant, intron_variant | Intron 6 of 45 | 5 | ENSP00000489861.1 | ||||
CACNA1A | ENST00000636389.1 | c.1082+1G>A | splice_donor_variant, intron_variant | Intron 7 of 46 | 5 | ENSP00000489992.1 | ||||
CACNA1A | ENST00000637432.1 | c.1082+1G>A | splice_donor_variant, intron_variant | Intron 7 of 47 | 5 | ENSP00000490617.1 | ||||
CACNA1A | ENST00000636549.1 | c.1082+1G>A | splice_donor_variant, intron_variant | Intron 7 of 47 | 5 | ENSP00000490578.1 | ||||
CACNA1A | ENST00000637927.1 | c.1082+1G>A | splice_donor_variant, intron_variant | Intron 7 of 46 | 5 | ENSP00000489715.1 | ||||
CACNA1A | ENST00000635895.1 | c.1082+1G>A | splice_donor_variant, intron_variant | Intron 7 of 46 | 5 | ENSP00000490323.1 | ||||
CACNA1A | ENST00000638009.2 | c.1082+1G>A | splice_donor_variant, intron_variant | Intron 7 of 46 | 1 | ENSP00000489913.1 | ||||
CACNA1A | ENST00000637276.1 | c.1082+1G>A | splice_donor_variant, intron_variant | Intron 7 of 45 | 5 | ENSP00000489777.1 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD3 exomes AF: 0.00000420 AC: 1AN: 238078Hom.: 0 AF XY: 0.00000776 AC XY: 1AN XY: 128884
GnomAD4 exome AF: 6.90e-7 AC: 1AN: 1449032Hom.: 0 Cov.: 28 AF XY: 0.00000139 AC XY: 1AN XY: 720534
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
Episodic ataxia type 2;C4310716:Developmental and epileptic encephalopathy, 42 Pathogenic:1
This sequence change affects a donor splice site in intron 7 of the CACNA1A gene. It is expected to disrupt RNA splicing. Variants that disrupt the donor or acceptor splice site typically lead to a loss of protein function (PMID: 16199547), and loss-of-function variants in CACNA1A are known to be pathogenic (PMID: 10371528, 19486177, 25735478, 27250579). The frequency data for this variant in the population databases is considered unreliable, as metrics indicate poor data quality at this position in the gnomAD database. Disruption of this splice site has been observed in individual(s) with clinical features of CACNA1A-related disease (internal data). It has also been observed to segregate with disease in related individuals. ClinVar contains an entry for this variant (Variation ID: 476232). Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant may disrupt the consensus splice site. For these reasons, this variant has been classified as Pathogenic. -
not provided Pathogenic:1
Observed as a heterozygous variant in a patient from a large cohort of individuals with epilepsy in published literature (PMID: 31440721); Canonical splice site variant predicted to result in a null allele in a gene for which loss of function is a known mechanism of disease; Not observed at significant frequency in large population cohorts (gnomAD); This variant is associated with the following publications: (PMID: 31440721) -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at